BCL11B 抗体
Quick Overview for BCL11B 抗体 (ABIN2666299)
抗原
See all BCL11B 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
交叉反应
- 小鼠, 斑马鱼
-
交叉反应 （详细）
- Mouse, Zebrafish
-
纯化方法
- Protein G affinity purified.
-
亚型
- IgG
-
-
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) (AA 1-150) antibody
BCL11B 适用: 人 ELISA, IHC, ICC, FACS 宿主: 小鼠 Monoclonal 1F8G8 unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) antibodyBCL11B 适用: 人 WB, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) (AA 1-150) antibodyBCL11B 适用: 人 ELISA, FACS 宿主: 小鼠 Monoclonal 1F8H9 unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) (Internal Region) antibodyBCL11B 适用: 人, 大鼠 WB, ELISA, IHC, IF, ICC 宿主: 兔 Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) (AA 395-444) antibodyBCL11B 适用: 人, 小鼠, 大鼠, Cow, 犬, 兔, 豚鼠, Pig, Bat, 猴 WB, IHC, IHC (p) 宿主: 兔 Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) antibodyBCL11B 适用: 人 WB, IHC 宿主: 兔 Monoclonal unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) antibodyBCL11B 适用: 小鼠, 大鼠 IHC, ICC 宿主: 兔 Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) antibodyBCL11B 适用: 小鼠, 大鼠 IHC, ICC 宿主: 豚鼠 Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) (AA 500-550) antibodyBCL11B 适用: 人 ELISA, IHC 宿主: 兔 Polyclonal unconjugated
anti-B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B) (C-Term) antibodyBCL11B 适用: 人, 小鼠, 大鼠, Cow, 犬, 兔, 豚鼠, Pig, 斑马鱼, Bat, 猴, 非洲爪蟾 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
缓冲液
- Hepes-buffered solution, pH 7.5, 0.02 % Sodium azide .
-
储存条件
- 4 °C
-
储存方法
- Upon receipt, store undiluted between 2°C and 8°C.
-
-
- BCL11B (B-Cell CLL/lymphoma 11B (Zinc Finger Protein) (BCL11B))
-
别名
- Bcl11b
-
背景
- The transcription factor Bcl11b is expressed in thymus, mainly T cells. It is indispensable for T lineage development. When Bcl11b was deleted, T cells from all developmental stages acquired NK cell properties and concomitantly lost or decreased T cell-associated gene expression. These induced T-to-natural killer (ITNK) cells, which were morphologically and genetically similar to conventional NK cells, killed tumor cells in vitro, and effectively prevented tumor metastasis in vivo. Therefore, ITNKs may represent a new cell source for cell-based therapies.
抗原
-
